Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,424 | -16,796 | -16,312 | -6,681 | -4,131 |
| Depreciation Amortization | -527 | -364 | -284 | -154 | -150 |
| Income taxes - deferred | 3,479 | -3,479 | N/A | N/A | N/A |
| Accounts receivable | -80 | 158 | 93 | 128 | 126 |
| Other Working Capital | 1,262 | -2,212 | -2,313 | -1,395 | -1,678 |
| Other Operating Activity | -1,841 | -220 | 430 | -4,750 | -1,127 |
| Operating Cash Flow | $16,717 | $-22,913 | $-18,386 | $-12,852 | $-6,960 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 11 | 157 | 17 | -4 | -2 |
| Other Investing Activity | 0 | 150 | 150 | 50 | 0 |
| Investing Cash Flow | $11 | $307 | $167 | $46 | $-2 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 7,788 | 7,788 | 4,512 | 2,656 |
| Other Financing Activity | 0 | 242 | 242 | 0 | 0 |
| Financing Cash Flow | $N/A | $8,030 | $8,030 | $4,512 | $2,656 |
| Exchange Rate Effect | 40 | 357 | 363 | 226 | 84 |
| Beginning Cash Position | 7,780 | 21,999 | 21,999 | 21,999 | 21,999 |
| End Cash Position | 24,548 | 7,780 | 12,173 | 13,931 | 17,777 |
| Net Cash Flow | $16,768 | $-14,219 | $-9,826 | $-8,068 | $-4,222 |
| Free Cash Flow | |||||
| Operating Cash Flow | 16,717 | -22,913 | -18,386 | -12,852 | -6,960 |
| Capital Expenditure | N/A | -4 | -4 | -4 | -2 |
| Free Cash Flow | 16,717 | -22,917 | -18,390 | -12,856 | -6,962 |